Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Oncoscience|January 17, 2015
Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancerGerald S Falchook, Aung Naing, Jennifer J Wheler, et al.
Oncotarget|July 9, 2014
Characteristics and survival of patients with advanced cancer and p53 mutationsRabih Said, Yang Ye, David S Hong, et al.
Oncotarget|May 15, 2013
P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapyRabin Said, David S Hong, Carla L Warneke, et al.
Investigational New Drugs|April 26, 2014
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapyMehmet Asim Bilen, Jean-Bernard Durand, Lacey McQuinn, et al.
The Oncologist|October 25, 2013
Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unitSiqing Fu, Lacey McQuinn, Aung Naing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analysesApostolia-Maria Tsimberidou, Sijin Wen, David S Hong, et al.
Cancer Research|October 16, 2012
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trialsFilip Janku, Jennifer J Wheler, Aung Naing, et al.
Cancer Chemotherapy and Pharmacology|June 12, 2016
Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trialsMehmet Asim Bilen, Amy Patel, Kenneth R Hess, et al.
Oncotarget|February 26, 2013
Dual EGFR inhibition in combination with anti-VEGF treatment: a phase I clinical trial in non-small cell lung cancerGerald S Falchook, Aung Naing, David S Hong, et al.
Investigational New Drugs|May 21, 2015
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liverRabih Said, Razelle Kurzrock, Aung Naing, et al.
Pageof 8